Literature DB >> 33646323

[Cognitive impairments in patients with depression].

Thomas M Schilling1, Magdalena Bossert2, Matthias Weisbrod3,4, Steffen Aschenbrenner2.   

Abstract

Cognitive impairments are frequent in patients suffering from major depressive disorders. They are among the first symptoms, often persist independently of improvement even after remission of the affective symptoms and are an important predictor of psychosocial functioning. In the clinical practice it is mandatory to ask about subjective complaints of the patient as well as to assess the cognitive abilities with the help of a standardized neuropsychological test battery. Cognitive remediation, selective serotonin reuptake inhibitors (SSRI) and vortioxetine as well as repetitive transcranial magnetic stimulation have proven their effectiveness as treatment options.

Entities:  

Keywords:  Diagnostics; Neuropsychology; Prevalence; Psychosocial functional level; Treatment

Mesh:

Substances:

Year:  2021        PMID: 33646323     DOI: 10.1007/s00115-021-01074-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  1 in total

1.  The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.

Authors:  R S McIntyre; J Harrison; H Loft; W Jacobson; C K Olsen
Journal:  Int J Neuropsychopharmacol       Date:  2016-06-15       Impact factor: 5.176

  1 in total
  1 in total

1.  Heart Rate Variability Changes in Patients With Major Depressive Disorder: Related to Confounding Factors, Not to Symptom Severity?

Authors:  Jan Sarlon; Angelica Staniloiu; Andreas Kordon
Journal:  Front Neurosci       Date:  2021-07-05       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.